ALUMIS INC. - 10-Q Filing

Alumis Inc. reports third quarter 2026 financial results and details collaborative revenue arrangements with Kaken Pharmaceutical Co. Ltd.

SEC EDGAR ·

Tickers: $ALMS

Read the full article at SEC EDGAR

More Regulatory news